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duration on the most recent ECG. 
Results: A total of 1,134 patients were actively enrolled in the program. of which 592 
(52%) had EF ~0.35. Out of this group, 62 (10%) were in atrial fibrillation or flutter and 55 
(9%) had a preexisting pacemaker, which would have excluded them from entry into 
MIRACLE. The table lists the demographlcs and ECG charactenstics of the remaining 
475 patlents who were in sinus rhythm. 
Table. Demographics and EGG characteristics of 475 patients with EF~0.35. 
Age ~65 years 
Z5 years 
Male 
Left bundle block 
Right bundle block 
IVCDt 
QRS <130ms 
rl30ms 
N (%) 
186 (39%) 
289 (61%) 
317 (67%) 
76 (16%) 
32 (7%) 
99(210/o) 
357 (75%) 
118 (25%) 
t QRS ZllOms but neither left nor right bundle block. 
Conclusion: Among 592 patients with symptomatic heart fatlure enrolled in a CHF cars 
management program who have EF $35, 118 (20%) met the ECG entry criteria used in 
the MIRACLE study. 
1090-19 Rapid Detection of Atrial Tachyarrhythmia in Pacemaker 
Patients Using Home Monitoring 
Andreas Hartmann, Christoph Stellbrink, Jas Gill, Massimo Santini, Eckhart Wunderlich, 
Diran Igidbashian, St. Georg Hospital, Leipzig, Germany 
Background: The current standard pacemaker follow-up scheme consists of regular 
clinical examinations every 3 to 6 months This may entail a significant delay for the reac- 
tion to cardiac events, a. g. atrial tachycardia (AT), especially if asymptomatic. Home 
Monitoring (HM) may present a solution, as it offers frequent data transmission from the 
implant to the physlcian. 
Methods: In a European multicenter clinical investlgatlon, patients having indications for 
dual chamber pacing have been implanted wth the pacemaker BA03 DDDR (Biotronik 
Inc.). The BA03 offers HM, i.e. automatically daily transfers a survey on mean ventricular 
rate, prevalence of intrinsic atrial and ventricular rhythm, atrioventricular conduction, and 
ventricular extrasystole via a GSM-net based mobile phone to a HM service center. The 
service center immediately sends the data to the physician via fax as so-called Cardio 
Report showing the latest data and the preceding data in tables and graphs. A patient 
may additionally trigger messages by applying a magnet. Primary endpoint of the study is 
the rellability of HM and will be presented elsewhere. We analyzed the clinical value of 
the transmitted data with respect to diagnosis of AT. 
Results: Hundred twenty two patients have been included. Follow-up with HM lasted 62 
* 23 days (mean * SD). 6425 HM messages are considered for the analysis. For 8 
patients, AT were documented by conventional means (24-h long-term-ECG, symp- 
toms). The onset of these AT could all be directly correlated to coincident changes of 
mean heart rate and atrioventricular synchrony in the HM data. However, similar 
changes were observed for 26 other patients. For 7 of these, the changes in HM param- 
eters could be correlated to other clinically relevant events, like lead dislocation and 
undersensing. Ten of the remaining patients were known to have paroxysmal AT, 
although no event could be documented by conventional means during inclusion. For the 
other 9 patients, the origin IS unclear. 
Conclusion: Home Monitoring offers the possibility for improving follow-up of pace- 
maker patients by reducing reaction time to clinically relevant events. Sensitivity to AT is 
sufficient, however, spectficity has to be Improved. 
1090-20 A Randomized Study of Three Tilt Test Protocols With 
Long-Term Follow-Up by Implantable Loop Recorder 
David J. Farwell, Neil Sulke, Eastbourne General Hospital, Eastbourne, United Kingdom 
Background: Head-Up tilt testing is an important tool in the diagnosis of syncope. We 
prospectively evaluated the clinical impact of three separate protocols. Methods: 214 
patients with recurrent syncope were randomized to one of three tilt protocols, Drug Free, 
GTN and Adenosine, with upright carotid sinus massage. Tilts were terminated at the 
onset of syncope, when systolic BP reached 60 mmHg or in the presence of prolonged 
hypotenslon (>3mins systokc BP&OmmHg). Appropriate empiric therapies were com- 
menced according to the result of the tilt test. 103 Patients were randomized to implant- 
able loop recorder “se &follow up, to cross correlate spontaneous syncopal events to tilt 
result, thus estimating the true sensitivity and specificity of tilt testing. Results were clas- 
sified according to published criteria. Results: 13 patients rewed pacemakers for class I 
indiacations. 
Tilt Test Result 
Negatwe 
Vase-vagal 
CSH 
Aut. Fail. 
Pseudseizure 
POTS 
Intolerant 
Adenosine 
75% 
15% 
10% 
0 
0 
0 
0 
Drug Free 
56% 
21% 
7% 
10% 
1% 
1% 
1% 
GTN All 
24% 52% 
55% 33% 
3% 6% 
2% 4% 
3% 1% 
3% 1% 
5% 2% 
All three protocols gave similar VASIS classification results. We were able to correlate 
spontaneous syncope to tilt result in 34 patients. Sensitivities for all (combined proto- 
cols), adenosine, GTN and drug free protocols were 33%, 33%, 100% and 0% respec- 
tively. Specificities were 64%. loo%, 60%and 71% respectively. Conclusions: A 
diagnosis was made in 47% of patients with syncope “sing tilt testing. The GTN protocol 
gave the most true positw results with the best sensitivity and specificity. 
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803-l The Canadian Registry of Atrial Fibrillation: Lack of 
Prognostic Differences Between Atrial Fibrillation and 
Atrial Flutter 
Paul A. LeLoner, Karin H. Humphries, Andrew Krahn, Stuart Connolly, Mario Talajic, 
Martin Green, Robert Sheldon, Paul Donan, David Newman, Charles R. Kerr, Raymond 
Yee, George J. Klein, Boston Medical Center, Boston, MA, University of Western 
Ontario, London, ON, Canada 
Background: The incidence of stroke is widely believed to be lower in atrial flutter (AFL) 
than in atrial fibrillation (AF) since the former represents an organized atrial rhythm. Con- 
vincing data to support this belief are not available. Methods: Between 1991 and 1996, 
1097 patients were enrolled in Canadian Registry of Atrial Fibrillation (CARAF) from six 
major clinical centers throughout Canada. Of these, 94 patients with atrial flutter (AFL) 
and 767 with atrial fibrillation (AF) met inclusion criteria. Patients were followed annually 
for a median of 6.9 years and 61.7% were male. End-points were compared between 
patients with AFL and AF using Cox proportIonal hazards models for time-to-stroke and 
mortality adjusted for warfarin “se and cardioversions. Results: The stroke rate was 
1.3%/person-year in the AF group and 1.2%/person-year in the AFL group. The death 
rate was 3.5%/person-year in the AF group and 2.9%/person-year in the AFL group. The 
hazard ratio of AFL versus AF for stroke was 0.76 (Cl 0.33 to 1.82) (p=O.56) and for rnor- 
tality 0.71 (Cl 0.42 to 1.20) (p=O.2). Age, history of stroke, diabetes, valvular heart dts- 
ease. congestive heart failure. left ventricular hypertrophy and a hypokinetlc ventricle 
wars associated with increased mortality, regardless of rhythm. The same risk factors, 
with the exceptton of diabetes and congestive heart failure, were associated with stroke, 
regardless of rhythm. The use of wariarin was the same in both groups (p=O.l). Conclu- 
sions: Neither nsk of stroke nor mortality differed between patients with AFL and AF. 
These results suggest the indications for anticoagulation should be the same for patients 
with either rhythm. 
9:30 a.m. 
803-2 Determinants of Improvement of Quality of Life in 
Persistent Atrial Fibrillation: Data From the RACE Study 
Vincent E. Haoens, Adelita V. Ranchor, Eric Van Sonderen, Jan H. Kingma, Hans A. 
Bosker. Otto Kamp, Tsjerk Kingma. Harry J. Crijns. lsabelle C. Van Gelder. for the RACE 
Investigators, University Hospital, Groningen, The Netherlands 
Background: Persistent atrial fibrillation (AF) may cause symptoms like fatigue, and 
dyspnea. This can impair quality of life (QoL). Treatment of AF with either rate or rhythm 
control may influence QoL. We sought to determine indicators of QoL changes during 
long-term follow-up. 
Methods: In 352 patients included in the RACE study (rate versus rhythm control I” per- 
sistent AF), QoL was assessed. Rats control patients (n=175) received negative chrono- 
tropic drugs, and oral anticoagulation (OAC). Rhythm control patients (n=177) underwent 
serial electrocardioversion. antiarrhyihmic drugs, and OAC as needed. QoL was 
assessed “sing the Short Form (SF)-36 health survey questionnaw at baseline and end 
of study (EoS), after2-3 years follow-up. Baseline and follow-up characteristics related to 
QoL Improvement were determined. 
Results Mean aoe is 66 * 9 “ears. oresent AF duration 1 month. 60% had underlwo 
I  
heart disease (49% class I, and 49% class II for heart failure), 70% had complaints ot Ai 
at inclusion. At the EoS, 10% versus 40% in rate versus rhythm control group were in 
sInus rhythm, respectively. Stepwise regression analysis showed that in the total group, 
sinus rhythm at EoS was related to a significant improvement of QoL (physical function- 
